Lista de obras - Roy Blum - Dominio Público Uruguay

A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

artículo científico publicado en 2014

Activation of muscle enhancers by MyoD and epigenetic modifiers.

artículo científico publicado en 2014

Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing".

artículo científico publicado en 2017

Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression

artículo científico publicado en 2017

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

artículo científico publicado en 2007

Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1.

artículo científico publicado en 2012

Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.

artículo científico publicado en 2011

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

artículo científico

Inhibitors of chronically active ras: potential for treatment of human malignancies.

artículo científico publicado en 2008

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

artículo científico publicado en 2014

Metabolism addiction in pancreatic cancer

artículo científico publicado en 2014

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

artículo científico publicado en 2009

Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation

artículo científico publicado en 2021

Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.

artículo científico publicado en 2012

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death

artículo científico publicado en 2005

Stepping inside the realm of epigenetic modifiers.

artículo científico

Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis

artículo científico publicado en 2006

Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

artículo científico publicado en 2005

The role of MyoD1 and histone modifications in the activation of muscle enhancers.

artículo científico publicado en 2013

Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function

article published in the Proceedings of the National Academy of Sciences of the United States of America

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome

scientific article published on 21 January 2019

Lista de obras de Roy Blum

A role for H3K4 monomethylation in gene repression and partitioning of chromatin readers.

Activation of muscle enhancers by MyoD and epigenetic modifiers.

Comment on "Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing".

Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3' UTRs to Regulate mRNA Expression

Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).

Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1.

Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

Inhibitors of chronically active ras: potential for treatment of human malignancies.

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Metabolism addiction in pancreatic cancer

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation

Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death

Stepping inside the realm of epigenetic modifiers.

Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis

Tailoring Ras-pathway--inhibitor combinations for cancer therapy.

The role of MyoD1 and histone modifications in the activation of muscle enhancers.

Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function

Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome